Бегущая строка

CYAD.BR $0.62 -0.639%
MLALV.PA $0.16 0%
OSPN $14.12 -1.7397%
0RWM.L $22.62 -0.273%
HRC $155.96 0%
PSQ $12.18 0.9536%
CCRC $6.50 0%
SACC $23.36 -0.2136%
AIVI $39.78 -0.5572%
WAVE.PA $47.00 0.5348%
AFL $65.66 -1.5149%
ENI.BR $13.69 0%
GLDW $152.82 0%
HOMZ $35.55 -0.1124%
ASX $6.85 -0.436%
PBAX $10.81 -0.0924%
HMFD.L $47.24 0%
HEU.PA $16.12 0.9328%
POG.L $1.20 0%
RJI $8.11 0%
INCO.BR $30.71 0%
ALVR $3.82 -9.0476%
XS8R.L $9 010.00 0.2225%
WTFCM $19.14 2.7927%
STRO $5.47 0.0916%
SBUX $105.27 -0.3408%
VTA.L $4.76 -3.4483%
FTCV $10.06 0%
JARU.L $1.00 0%
VLN $2.38 -4.6185%
FXB $119.81 -0.2997%
FTAA $10.17 0%
0P00018Q2R.L $10 103.30 0.5283%
0078.HK $3.09 -0.3226%
AFMD $0.86 -5.8303%
ZGBR $48.82 0%
BOXL $0.31 -7.0875%
HE1.L $6.90 -2.8169%
ENCG.L $1 043.50 -0.4864%
PNQI $140.64 -1.6101%
EXR.IR $0.04 0%
0176.HK $0.02 0%
YRD $2.30 -9.902%
FLGT $35.01 1.8028%
BZT.L $0.04 2.5882%
SDC $0.38 -2.918%
AESB3.SA $12.70 1.6813%
ANRJ.L $28 010.00 -1.7624%
6878.HK $0.11 -10.2564%
PIII $2.54 9.9567%
VEMT.L $32.90 0.0435%
UC76.L $14.15 -4.40804%
IIAC $10.14 0%
FLRG.L $21.90 0.2633%
AGR.L $50.65 -0.197%
BLX $18.61 1.4169%
GILE.L $4.58 -0.1635%
A7RU.SI $0.49 0%
3623.HK $0.70 0%
0P0000KM1W.L $21 362.50 -0.0734%
KTH $29.34 0.4478%
NBSTU $10.40 0%
SGEN $198.92 -0.2932%
CFFEW $0.04 0%
ARG.PA $71.60 -1.9178%
HEAR $10.71 -2.9891%
SLGG $0.66 -3.4118%
OCUL $6.14 -1.84%
MLHYD.PA $600.00 0%
TKNO $2.01 7.4866%
AEM $56.61 -0.2994%
ALTO $1.99 -7.8287%
8348.HK $0.31 0%
SEUC.L $29.15 -0.0662%
ANET $137.23 -1.2805%
VID.L $722.00 -1.2312%
HTIA $18.03 -0.3867%
FRAF $24.90 -0.1604%
PGMN3.SA $3.05 -1.6129%
WBIG $21.64 -0.4197%
RTC.L $17.00 0%
ALCES.PA $0.04 0%
VELOW $0.00 0%
VIV.PA $9.72 -0.3485%
IMAQR $0.10 0%
1166.HK $0.04 0%
ANTIN.PA $14.81 1.0232%
8260.HK $0.04 0%
BIOC $0.25 1.1124%
P60.SI $6.33 0%
USB $29.01 0.3112%
EPIC.L $62.40 0.6452%
CN1.L $49 837.50 0.7123%
RILYG $17.51 -1.8498%
O5RU.SI $1.34 -1.7206%
BGIP3.SA $26.40 0%
1104.HK $1.00 -4.7619%
MYOV $26.98 0%
0JZU.L $389.42 -0.8542%
3948.HK $16.84 -0.4728%

Хлебные крошки

Акции внутренные

Лого

vTv Therapeutics Inc. VTVT

$0.85

-$0.04 (-4.49%)
На 18:01, 12 мая 2023

+488.24%

Потенциал через год

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    73335240.00000000

  • week52high

    1.40

  • week52low

    0.38

  • Revenue

    2018000

  • P/E TTM

    -3

  • Beta

    -1.19446300

  • EPS

    -0.27000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    10 мая 2023 г. в 10:05

Описание компании

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approach to activating the Nrf2 pathway for the treatment of chronic diseases associated with oxidative stress; azeliragon, a RAGE antagonist for inflammatory lung diseases, including severe COVID-19, as well as for pancreatic and breast cancers; and HPP971, an Nrf2 activator for renal diseases through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc. also has license and research agreements with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; and Novo Nordisk A/S. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.

Рекомендации аналитиков

Grading company New grade Previous grade Recommendation date
Northland Capital Markets Outperform Outperform 17 авг 2022 г.
Cantor Fitzgerald Overweight 18 февр 2022 г.
H.C. Wainwright Buy 10 февр 2020 г.
H.C. Wainwright Buy 30 мая 2019 г.
Northland Capital Markets Outperform Market Perform 06 мая 2019 г.
HC Wainwright & Co. Buy 10 февр 2020 г.
HC Wainwright & Co. Buy 30 мая 2019 г.

Свежие комментарии

Свежие комментарии

Оставьте свой голос

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%
  • Нет

    12%

Проголосовал 8 человек

Новостная лента
компании

Новостная лента

  • Изображение

    Promising Upsides on these Biotech Penny Stocks

    MarketBeat

    18 апр 2023 г. в 08:17

    For investors willing to do their research and take calculated risks, biotech penny stocks can offer the potential for high returns. These companies have a low market capitalization and are not yet profitable, but they offer the potential for high growth as their products gain regulatory approval and market acceptance.

  • Изображение

    10 Hot Penny Stocks Under $1 To Watch This Week

    PennyStocks

    09 мар 2023 г. в 14:31

    Penny stocks under $1 to watch right now. The post 10 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  • Изображение

    7 Hot Penny Stocks Under $1 To Watch This Week

    PennyStocks

    07 мар 2023 г. в 14:23

    Penny stocks under $1 to watch this week. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  • Изображение

    Best Penny Stocks To Buy Under $1? 4 To Watch Now

    PennyStocks

    06 мар 2023 г. в 12:19

    Finding the best penny stocks to buy seems easy.

  • Изображение

    7 Drug Stocks That Will Soar in 2023

    InvestorPlace

    22 дек 2022 г. в 06:00

    Choosing the best drug stocks to buy can be dicey because drug stocks have disadvantages and advantages. On the negative side, you often have to wait many years for promising drugs to prove themselves in clinical trials.



Insider Summary

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
Tuch Steven L. A 500000 500000 12 дек 2022 г.
FRY JOHN A A 61000 40461 29 ноя 2022 г.
FRY JOHN A A 20539 20539 28 ноя 2022 г.
Isaacsohn Jonathan A 50000 50000 17 авг 2022 г.
Harris Keith R. A 25000 25000 13 июл 2022 г.
Al-Marzooqi Fahed A 25000 25000 13 июл 2022 г.
FRY JOHN A A 137077 137077 01 июл 2022 г.
Harjivan Chandresh A 25000 25000 01 июл 2022 г.
KOZLOV HERSH A 105128 105128 01 июл 2022 г.
Weiner Howard L. A 105128 105128 01 июл 2022 г.